Manufacturing Investors
Manufacturing is one of the most actively funded categories on CapLink, with 1234 verified investors currently backing companies in the space.
The mix is led by PE/Buy-Out, VC and Corporate VC, alongside 6 other investor types. Deal coverage spans Pre-Seed through Secondaries, with the largest concentration at PE/Buy-out.
Investor headquarters cluster in United States, Canada, South Africa, Mexico and China, with activity across 194 countries in total. Ticket sizes range from roughly $20K to $20000M, covering early angel cheques through to growth-stage rounds.
Use the pre-filtered database below to explore every Manufacturing investor on CapLink, or sign up to unlock contact details, ticket sizes and detailed investment criteria.
Manufacturing investor database
1234 investors matched for Manufacturing. Sign up to unlock contact details and full profiles.
| Investor |
|---|
![]() 8VC 8VC is a technology and life sciences venture capital firm that builds and invests in transformative companies across various sectors, including life sciences, healthcare, manufacturing, enterprise, logistics, and defense. Founded in 2015 by Joe Lonsdale, a co-founder of Palantir Technologies, the firm is headquartered in Austin, Texas, and manages over $6 billion in committed capital. 8VC's mission is to "fix a broken world" by partnering with entrepreneurs to develop innovative solutions to complex global challenges.
The firm invests at all stages of a company's lifecycle, from seed to growth, and also builds companies through its 8VC Build program. Notable portfolio companies include Palantir Technologies, Anduril Industries, and Guardant Health. 8VC's investment philosophy emphasizes long-term value creation and societal impact, focusing on sectors that have the potential to drive significant positive change.
The firm's team comprises experienced professionals with diverse backgrounds in technology, finance, and entrepreneurship, enabling them to provide comprehensive support to their portfolio companies. |
ABB ABB is a global technology leader specializing in electrification and automation, committed to enabling a more sustainable and resource-efficient future. With a workforce of approximately 110,000 employees worldwide, ABB has a rich history spanning over 140 years. The company was formed in 1988 through the merger of Sweden's Allmänna Svenska Elektriska Aktiebolaget (ASEA) and Switzerland's Brown, Boveri & Cie, combining their expertise in electrical equipment manufacturing.
ABB's core activities include power generation, transmission and distribution, industrial automation, and robotics. The company invests around 4 to 5 percent of its annual revenues in research and development, collaborating with customers and partners to drive technological innovation. Sustainability is central to ABB's purpose, as it works with stakeholders to promote a low-carbon society, preserve resources, and support social progress toward a net-zero future.
( |
![]() KKM KKM is a principal investment firm specializing in direct and fund of funds investments. The firm specializes in growth capital investments. It prefers to make early to middle stage investments in innovative start-ups. The firm seeks to invest in advanced manufacturing, consumption, environmental protection, food safety testing. It invests in cross-regional agricultural product infrastructure and foreign trade comprehensive services platform in Guizhou Province. The firm was founded in 2014 and is headquartered in Guiyang, China. |
M80 M80 is a private equity firm specializing in middle market, later stage, mature, buyout, and growth capital investments. The firm primarily invests in the consumer, healthcare, business services and manufacturing sector. It does not invest in real estate, R&D based life sciences, and pre-commercial technology companies. It typically invests in companies in Belgium, the Netherlands, Luxembourg and France. The firm makes equity investments between €10 million ($12.05 million) and €60 million ($72.28 million) in companies with sales values between €25 million ($30.12 million) and €300 million ($361.4 million), an EBITDA between €5 million ($6.02 million) and €30 million ($36.14 million) and an enterprise value between €25 million ($30.12 million) and €250 million ($301.17 million). The firm prefers to have a majority stake in portfolio companies. M80 was founded in 2018 and is based in Brussels, Belgium. |
![]() AICA AICA is a non-profit organization designed to foster the development of entrepreneurial environment in Armenia . It is created to help start-ups and entrepreneurs with innovative ideas find high-caliber business professionals who would invest and help steer companies in their endeavors of high impact and growth. AICA is 20 members strong and growing.
AICA brings together a very diverse group of CEOs, Entrepreneurs and Business Professionals from Armenia, Russia, Germany, Austria, Denmark, and the USA. Its members represent various industries ranging from cutting edge sphere in Biotech, Digital Healthcare, IT, Blockchain, Artificial Intelligence, Biometrics to more traditional sectors of Manufacturing, Construction, Real Estate Development, Renewable Energy, Banking, Fin-tech, Food & Beverage, Consumer Products, Logistics and Retail. AICA boasts 5 members from YPO and members from top business schools from Armenia, Europe, and USA, including 3 graduates of Harvard Business School. Members of AICA serve on Boards of Multinational Companies and run VC funds; They are Serial Entreprenuers with multiple successful companies under their belts and Top-Notch experts in Management, International and US Law, International Marketing, Sales and Distribution; They invest as Angels in companies with high growth potential and guide them through the exciting but challenging path to success; They open doors to New Markets and Clients and dedicate their Networks, Connections, and most importantly Knowledge, Experience, and Time to help companies Beat the Market Odds. |
![]() E2MC E2MC is a venture capital firm specializing in seed and pre-seed stage investments. The firm typically invests in space-related technology companies in all major space subsectors, including but not limited to launch, satellite communications, remote sensing, spacecraft hardware, materials, space tourism, in-orbit services, lunar economy, space resources and microgravity manufacturing. The firm seeks to invest in globally with a focus on U.S. The firm assume $0.25 million and $2 million for first checks. E2MC was founded in 2020 and is based in Orlando, Florida with additional offices in Sao Paulo, Brazil and Zurich, Switzerland. |
![]() EDBI EDBI is the corporate investment arm of Singapore's Economic Development Board (EDB), established to support the growth and development of Singapore's economy by investing in innovative and high-growth companies. With a focus on sectors such as technology, healthcare, and advanced manufacturing, EDBI aims to foster strategic partnerships and drive economic transformation. The firm leverages its deep industry knowledge and extensive network to identify and support companies that can contribute to Singapore's economic development.
EDBI's investment philosophy centers on long-term value creation, and it actively collaborates with portfolio companies to enhance their growth and global competitiveness. Notable achievements include successful investments in companies that have expanded their operations in Singapore, contributing to job creation and technological advancement. EDBI differentiates itself through its strong government backing, providing unique access to resources and opportunities that private investors may not have.
This support enables EDBI to take a long-term investment approach, focusing on sustainable growth and economic impact. The firm's geographic focus is primarily on Singapore, but it also considers investments in companies with a strategic interest in the region. |
![]() K2VC K2VC, also known as 险峰, is a Chinese venture capital firm headquartered in Beijing, specializing in early-stage investments. Founded in 2010 by Chen Keyi and Bao Fan, the firm focuses on angel investing and has invested in over 700 companies as of 2024. K2VC manages both RMB and USD-denominated funds, with assets under management totaling approximately 10 billion RMB as of 2022.
The firm's investment platforms include 险峰长青, which focuses on industrial angel investments, and 险峰淇云, which specializes in early-stage investments in the life sciences and healthcare sectors. K2VC is committed to supporting entrepreneurs in technology, media, telecommunications, advanced manufacturing, new energy, industrial digitalization, and new economy sectors. The firm's name, K2, is derived from the world's second-highest mountain, symbolizing the firm's dedication to guiding entrepreneurs in their pursuit of excellence. |
![]() TGVP TGVP is corporate venture capital arm of TOPPAN Holdings Inc. specializes in startup, post-seed, growth stages, series A and growth capital. The firm prefers to invest in manufacturing, material, fintech, enterprise SaaS, healthcare, lifescience, AI/ML, cybersecurity, internet-of-things, automation, communications, health, clean energy, green materials, and decarbonization. The firm prefers to invest in North America. TGVP was founded in 2022 and is based in San Mateo, California. |
![]() XSML XSML is a private equity and venture capital firm specializing in direct and funds of funds investments. Within the direct investments, it specializes in seed, start up, SMEs, early venture, emerging growth, growth capital, mid venture, later stage, buyout, and mezzanine investments in small and medium-sized companies. The firm also specializes in venture debt investments and offers loans. For fund of fund investments, it seeks to invest in mezzanine funds. It primarily invests in agribusiness, electronic/ electrical equipment, education, healthcare, financial services, information communications and technology (ICT), transportation, hospitality, warehousing, tourism, and retail & wholesale, manufacturing, business support service sector. The firm seeks to invest in emerging markets with a focus on Democratic Republic of the Congo, Central and East African Republic, South Sudan, Uganda, Zambia, Kenya, Burundi, Rwanda, Africa, Asia, and Latin America. The firm invest between $0.3 million and $10 million. It prefers to make equity investment between $0.1 million and $7.5 million and debt investments between $0.2 million to $5 million with sales range between $1 million to $25 million. For fund of fund investments, it typically invests between $5 and $25 million. The firm prefer to take a majority stake. XSML was founded in 2008 and is headquartered in Amsterdam, the Netherlands with additional offices in Kampala, Uganda; Kinshasa, Democratic Republic of Congo, Launda, Angola; and Nairobi, Kenya. |
Da VC We invest in US and EU-based industrial tech and deep tech startups - backed by the thesis that age-old industries such as manufacturing, supply chain, and construction are finally catching up to the adoption of digital tools, AI, and automation. |
![]() JIMCO Abdul Latif Jameel is a diversified business of independent entities that include automotive distribution, auto parts manufacturing, financial services, renewable energy, environmental services, health, land and real estate development, logistics, electronics retailing and media services. |
![]() v1.vc V1.VC is a venture capital firm that partners with highly technical founders building AI-native and frontier technology. They focus on software and hardware solutions for critical real-world industries including autonomous agents, developer infrastructure, aerospace, energy, robotics, and advanced manufacturing. |
Abraaj The Abraaj Group is a private equity, venture capital, and real estate investment firm specializing in early venture, seed, growth capital, emerging growth, mid venture, late venture, expansion capital, industry consolidation, mezzanine, subdebt, PIPES, buyouts, bridge, recapitalization, infrastructure, and buy and build in mature companies. It seeks to invest in small and medium sized enterprises in emerging markets. The firm typically invests in oil, gas and consumable fuels, metals and mining, agricultural machinery and equipment, agricultural services, auto parts and equipment, leisure facilities, pharmaceuticals, services outsourcing, water utilities, real estate, health care and clean energy, manufacturing, food products, FMCG, construction, healthcare services, industrials, telecommunications, resource and infrastructure services, education, information technologies, aviation, materials and logistics, agribusiness, energy, and food industries. It focuses on consumer goods and services, within which it also focuses on fast moving consumer goods manufacturing, retail, and food & beverage. Within financial services it also focuses on banking, non-bank financial institutions (such as mortgage or consumer finance specialists), insurance companies (life, general and reinsurance), and payments and fintech businesses. Within healthcare it focuses on hospitals & clinics and other type of service providers in the healthcare domain. Within education, it focuses on private K-12 schools and traditional graduate and post-graduate, campus-based universities. We are also investing in clean energy power generation, i.e., renewable power generation assets. We will also selectively invest in base-load gas-fired power generation assets and select midstream and downstream energy infrastructure assets including transmission and distribution assets that complete the value chain. It invests in companies based in Far East, the Middle East including Saudi Arabia, North Africa, Kenya, Ghana, Nigeria, and South Asia with a focus on Egypt, Lebanon, Jordan, Algeria, Pakistan, Turkey, the Palestinian territories and the six Gulf Arab nations that make up the Gulf Cooperation Council. The firm also seeks to invest globally with a focus on Sub Saharan Africa including Ivory Coast region; Latin America including Argentina, Brazil; Central Asia; and Southeast Asia including India and the Philippines. The firm seeks to make equity investments between $0.5 million and $100 million; typically investing $10 million to $100 million in private equity investments as well as in real estate. It prefers to invest between $100 million and $300 million in its portfolio companies. It prefers to invest in companies with revenue between $6 million to $35 million. The firm acquires controlling or significant interest and seeks board representation in its portfolio companies. It typically exits its investments within a period of three years to five years through structured exits to strategic and trade buyers or onto public markets in the region. The firm seeks majority and minority positions in public enterprises ranging between 10% and 49%. The Abraaj Group was founded in 2002 and is headquartered in Dubai, United Arab Emirates with additional offices across Asia, Africa, and Europe. |
Kompas Kompas VC is an early-stage venture capital firm founded in 2021, headquartered in Copenhagen, Denmark. The firm specializes in investing in sectors such as prop tech, construction tech, climate tech, Industry 4.0, and enterprise software. With a fund size of $160 million, Kompas VC focuses on late Seed and Series A technology companies across Europe, Israel, and the United States.
The firm's investment strategy centers on supporting ambitious founders who develop technologies to transform buildings into more sustainable and healthy spaces, reduce the environmental impact of the construction and manufacturing industries, and enhance organizational operations through digital technology and automation. Kompas VC has offices in Amsterdam, Berlin, Copenhagen, and Tel Aviv, and has completed 17 investments to date. |
Lagata Lagata is a private equity and venture capital firm specializing in growth markets and emerging markets. The firm prefers to invest in agriculture & agri- processing, forestory, manufacturing, natural resources and technology sectors. The firm focuses on Sub Saharan Africa region. Lagata is headquartered in London, United Kingdom. |
Midven Midven Limited is a private equity and venture capital firm specializing in investing in seed/start-up, early stage, growth, emerging growth, management buy-outs, and management buy-ins investments in small and medium sized enterprises. It does not invest in land, commodities, futures, shares, securities or other financial instruments; dealing in goods (other than in normal wholesale or retail trades); banking, insurance, money lending, debt factoring, hire-purchase financing and other financial activities; property development; farming, forestry or market gardening; operating or managing hotels or nursing or residential care homes. It also does not invest in ‘Restricted Sectors’ referred to in Article 32 of the EC Treaty. These include certain agricultural, and food related sectors and other sectors of which examples are synthetic fibres and yarns, motor vehicles and certain heavy industries. The firm does not provide grant funding. The firm is sector agnostic and prefers to invest in companies working in the field of technology, synthetic biology, manufacturing, engineering, medical, biotechnology, environmental technologies, information & communication technologies (ICT), digital media, saas, software, hardware, consumer, and service sectors. It invests in the Midlands region of United Kingdom with a focus on West Midlands, Shropshire, Staffordshire, Warwickshire, Worcestershire, Herefordshire, and the Metropolitan Borough of the West Midlands (Birmingham, Coventry and the Black Country) with exception for the Rainbow Seed Fund. It seeks to invest between $0.02 million and £5 million ($6.44 million) in its portfolio companies with a turnover up to €40 million ($45.06 million), net assets of no more than €27 million ($ 30.41 million), minimum EBITDA of £0.25 million ($0.35 million) and sale value maximum €40 million ($45.06 million) and debt investment value between £0.025 million ($0.03 million) to £2 million ($2.57 million). The firm invests through a mixture of ordinary equity shares and either redeemable preference shares, subordinated loans and quasi equity instruments. It always takes an equity stake in its portfolio companies and assumes role of board members or advisors. The firm seeks to exit from an investment within five to seven years through trade sale. Midven Limited was founded in 1990 and is based in Birmingham, United Kingdom with an additional office in London, United Kingdom and Harwell, United Kingdom. As of April 8, 2021, Midven Limited operates as a subsidiary of Future Planet Capital. |
Newlab Newlab is a multidisciplinary technology center located in Brooklyn, New York, dedicated to fostering innovation in hardware-focused startups. Established in June 2016, Newlab occupies Building 128 of the Brooklyn Navy Yard, a historic site with a rich manufacturing heritage. The center provides a collaborative workspace, research labs, and prototyping facilities for companies specializing in robotics, connected devices, energy, nanotechnology, life sciences, and urban tech.
By offering access to advanced manufacturing tools and a supportive community, Newlab aims to accelerate the growth of emerging hardware technologies. As of 2018, over 100 companies were operating within Newlab, with members typically being growth-stage companies with 3-20 employees. |
Oriens Oriens is a private equity firm specializing in providing growth and expansion capital at middle market stages. It also specializes in making investments for bolt-on acquisitions. The firm seeks to invest in manufacturing, services, business services, healthcare, media, retail, financial services, macroeconomics, information and communication technology services, energy, and environmental services sectors. The firm typically invests in Central Eastern European businesses with a focus on Czech Republic, Hungary, Slovakia, South Poland, Moldova, Romania, and Bulgaria. It seeks to invest between €2 million ($2.23 million) and €15 million ($16.75 million) in companies with enterprise value between $10 million and $15 million. The firm invests for a period of three to five years. It invests through equity or equity-type securities via capital increases and in some cases, partial buyout of shares. It takes a prudent approach to debt in its transactions. The firm invests in companies where the original owners retain a stake. It acquires controlling stakes in its portfolio companies and takes a seat on their Boards. The firm prefers to take majority positions in its portfolio companies. It also prefers to make follow-up acquisitions and integrate the portfolio companies onto the platform. It provides capital to increase capacity, develop and roll-out a service offering or a product, finance add-on acquisitions, and secure working capital for the growth of the companies. Oriens was founded in 2007 and is based in Budapest, Hungary with additional offices in Warsaw, Poland; Sofia, Bulgaria; Singapore, Singapore; Prague, Czech Republic; and Bucharest, Romania. |
![]() VICOUR VICOUR is a private equity firm specializing in acquisitions and lower middle market investments. It seeks to invest in various industries specifically business services, consumer services, niche financial services, value-added distribution, and equipment dealers. It also invests in products including niche manufacturing and consumer products. The firm invests in education such as curriculum products, services and digital education. In the healthcare sector it invests in senior care and private pay models. It prefers to invest in the companies headquartered in eastern half of United States, Maryland or Mid Atlantic region. It invests in the companies with EBITDA trailing between $2 million to $6 million. VICOUR is based in Baltimore, Maryland. |
AI Fund AI Fund is a venture studio dedicated to building AI-based companies. Acting as a minor co-founder, they partner with innovators and tech pioneers to launch new ventures together. Their portfolio spans diverse sectors, including manufacturing, mental health, maritime shipping, education, and training, reflecting their commitment to revolutionizing industries through innovative AI applications. |
BeiGene BeiGene is a global biotechnology company specializing in the discovery, development, and commercialization of innovative molecularly targeted and immuno-oncology drug candidates for the treatment of cancer. Founded in 2010, the company has rapidly expanded its presence worldwide, with operations in the United States, China, and other international markets. BeiGene's mission is to improve the accessibility and affordability of cancer treatments through a science-first approach, focusing on producing high-quality therapies efficiently.
The company has developed a robust oncology pipeline addressing a significant portion of global cancer incidences, conducting over 140 clinical trials with more than 20,000 patients. Notable achievements include receiving regulatory approvals in over 70 markets for three internally developed medicines and establishing a state-of-the-art biologics manufacturing facility in Hopewell, New Jersey, to expand production capabilities. This facility is expected to employ hundreds of workers and support the company's broader expansion strategy to deliver innovative medicines to a global patient population. |
GEMCORP Our mission is to realise the vast opportunities found in the emerging markets and back the remarkable people that make them what they are.
We have a deep understanding of this growth potential because we see it from the ground. We grow and thrive together with our local partners, gaining a distinct and disruptive perspective on global finance.
Global emerging markets are in our name, in our DNA and are the very fabric of our businesses:
Our founders proudly hail from emerging economies and have witnessed first-hand the power of historical economic transformations.
With individuals from 32 different countries who speak 24 languages, our teams are as diverse as the populations we serve. This native insight and our explorer spirit make us better investors and help us foster strong relationships.
Our teams have navigated multiple emerging market cycles and have a proven track record of closing deals and creating success.
We have designed our internal structures and processes to ensure a fast, bespoke and comprehensive approach to the funding and logistical needs of our partners.
We have the expertise and systems in place to invest and hedge across financial products in order to mitigate volatility and maximise returns. And just as importantly, we do so with an integrity that allows us to look our partners in the eye.
We have a deep respect and affinity for our host countries, their cultures, their histories and the future we are writing together.
NURTURING GROWTH AND OPPORTUNITY
FOR GENERATIONS TO COME.
At Gemcorp, we strive to make a positive and lasting impact on the communities we invest in. We support businesses and organisations that are driven by a desire to achieve excellence and share our commitment to positively impact those most in need within the emerging markets.
Through nearly US$1 billion in innovative sovereign trade financing, we have delivered over 976,000 tons of basic foods and non-edible goods, as well as over 948 million units of essential medical supplies and pharmaceuticals to approved local importers in Angola.
In order to ensure the quality and proper handling of pharmaceutical goods delivered to Angola, we have established a pharmaceutical warehousing complex close to Luanda, helping to close a critical infrastructure gap in the healthcare supply chain.
With a US$122 million government-backed financial plan that we helped organise, a flagship 5,000-hectare farming project was launched in Quizenga, Angola. Initial crops are already producing, and the project will be fully operational in 2021, creating 1,200 new jobs for the local community.
DISRUPTIVE APPROACH
With our unique strategy, we are delivering local solutions to Africa’s energy needs through modular refineries located close to major oil producing areas. Our refineries are developed using the latest US design, manufacturing and operational technology, along with long-term local content planning, which allows us to maximise local job creation.
CORPORATE EXPERTISE
With experience in oil and gas project development management and operation, our team are able to leverage our corporate expertise in early-stage investing, commodities trading, and asset operation.
SUSTAINABLE LOCAL SOLUTIONS
We fully integrate environmental, social and governance factors into our operational processes and into the management of our refineries. This strict adherence ensures our assets meet the latest guidance set out in the Equator Principles. |
![]() IT Farm IT-Farm Corporation is a venture capital firm which specializing in incubation, seed, start-up, and early-growth companies. It primarily invests in semiconductor, network, mobility, IT, healthcare, manufacturing, sustainability, FinTech, and media related industries. The firm typically invests in companies based in Japan and in Asia, as well as in U.S. corporations if business and technology seeds are originally created in Japan or by Japanese nationals based in the U.S. IT Farm Corporation was founded on 1999 and is based in Tokyo, Japan with an additional office in Palo Alto, California. |
Karnell Our basic concept is to invest in companies with good opportunities for development, where we can add value as an active owner. So that we can act decisively, we only invest in companies as a majority owner with the opportunity to make quick decisions when necessary. Our investments are made via our own balance sheet and we have no stated investment horizon. Our main focus is on smaller unlisted companies that operate within the industrial sector. This typically includes companies that carry out their own manufacturing, development and sales of industrial goods and services, trading in input goods or systems solutions for industry. |
Understanding Manufacturing investors
What are Manufacturing investors, and what do they look for?
Investors backing manufacturing businesses first establish whether you make things or enable others to make them. Owning production means capital equipment, facilities, working capital and utilisation risk, financed largely with debt and asset finance rather than equity. Selling equipment, software or services to manufacturers is a product business with conventional venture economics. The two attract entirely different investors and confusing them wastes meetings. For businesses that own production, utilisation is the number everything turns on. Factories have high fixed costs, so the difference between running at capacity and running at half capacity is the difference between profit and loss. Investors examine order book depth, customer concentration and how utilisation has moved through the year. Third, they assess where you sit in the cost structure. European manufacturing competes against lower-cost locations, and businesses that win do so on proximity, quality, speed, regulatory compliance or complexity rather than on price. Investors want to hear which of those you rely on and whether it holds if a competitor invests in the same capability elsewhere.
Why Manufacturing is attracting investor interest
Cost advantage stopped being the only variable, which is what has made European manufacturing investable again. Supply disruption, shipping costs, tariff uncertainty and lead times taught buyers that the cheapest unit price is not the lowest total cost, and proximity acquired a value it had lacked for two decades. Regulatory requirements added a second reason to produce locally. Rules covering product safety, materials, emissions reporting and increasingly supply chain due diligence are easier to satisfy with production inside the jurisdiction, and some sectors face requirements that effectively mandate it. Defence and strategic sectors created demand that is explicitly not price-driven. Governments buying capability they consider sovereign will pay for domestic production, and that has supported manufacturing investment that commercial logic alone would not. Labour scarcity works against all of this and is the constraint investors weigh most heavily. European manufacturers cannot recruit skilled production staff, which caps output regardless of demand and makes automation a prerequisite rather than an optimisation for any business planning to grow.
Which funding stages Manufacturing investors are active at
Funding depends entirely on which side of the make-or-enable line the business sits. Equipment, software and service businesses serving manufacturers follow conventional stages, with Series A requiring repeatable sales into industrial buyers and later rounds turning on deployment repeatability and retention. Production businesses raise differently. Equity funds the team, technology and initial capability while facilities and equipment are financed with asset finance, leasing, debt and frequently public industrial support. Investors assess whether that stack can be assembled, since venture equity alone cannot fund a factory. Working capital is the persistent constraint for anyone producing physical goods, because materials and labour are paid for well ahead of customer payment, and growth widens the gap. European public funding for industrial capacity, reshoring and strategic sectors is substantial and specifically intended for capital intensity that private venture will not carry. Companies treating it as a core channel reach the same position considerably less diluted than those that do not.
Types of investors active in Manufacturing
Investors who understand utilisation economics, order book quality and why European production competes on attributes other than price. They are comfortable with asset-heavy structures that conventional venture funds will not underwrite.
Providers financing machinery and facilities against the equipment itself. Structurally necessary for any production business, since funding capital equipment from equity dilutes founders for something a lender would readily provide.
Corporate investors who are also buyers, providing order book visibility and technical validation. A committed offtake from a credible industrial buyer changes what a production business can finance.
European and national programmes supporting manufacturing capacity, strategic sectors and industrial modernisation. Central to financing facilities, and frequently conditioned on location, employment and technology retention.
Venture capital for companies selling into manufacturers rather than operating plants. Conventional software and hardware economics, and the more accessible funding path for founders without access to industrial-scale capital.
Ready to reach Manufacturing investors?
Create a free CapLink account to unlock full investor profiles, contact details, ticket sizes and intelligent matching.











